← All medicines
Repaglinide Teva 0.5 mg Tablet
Licence EU/1/09/530/1-5 · Unknown
- Licence holder
- Teva Pharma B.V. (all products →)
- Active substance
- Repaglinide
- Dosage form
- Tablet
- Route of administration
- Oral use
- ATC codes
- A10BX, A10BX02
- First authorised
- 29/06/2009
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.